COV
Pharmaceuticals, Biotechnology & Life Sciences
Cleo Diagnostics
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 24 Aug 2026
- Reported shorts
- 6.3K
- Shares on issue
- 137.112M
Cleo Diagnostics (COV) company profile
Profile, insiders and operations
Company
AI-generated research profile of Cleo Diagnostics
medical diagnostics
ovarian cancer
biotechnology
ASX
COV
Cleo Diagnostics is a medical diagnostics company focused on developing and commercializing novel cancer diagnostic solutions, particularly for ovarian cancer. Their focus is on creating accessible and accurate diagnostic tests. The company aims to improve early detection and treatment outcomes for women's health.
COV intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required